High materiality7/10
Nurix Therapeutics price target raised to $41 from $40 at Stifel
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Stifel Nicolaus raises NRIX price target to $41 from $40; current price $22.16.
- Stifel Nicolaus raises NRIX price target to $41 from $40; current price $22.16.
Key facts
- 01
Target: $41
- 02
Posted price: $22.16
- 03
Analyst firm: Stifel Nicolaus
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.